Cellebrite Di LTD Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
SUNCORPORATION has filed an amendment to its Schedule 13G, confirming its beneficial ownership of 42.67% of Cellebrite DI Ltd.'s ordinary shares.
NASDAQ
FMR LLC and Abigail P. Johnson have disclosed a reduction in their passive beneficial ownership stake in Cellebrite DI Ltd. to 4.1% of common stock as of March 31, 2025.
NASDAQ
SCHEDULE 13G: FMR LLC Discloses 5.2% Stake in Cellebrite DI Ltd.
FMR LLC, the parent company of Fidelity Investments, has disclosed a 5.2% beneficial ownership stake in Cellebrite DI Ltd. as of December 31, 2024, held in the ordinary course of business.
NASDAQ
SCHEDULE 13G/A: Investment Group Divests Full Stake in Cellebrite DI Ltd., Key Individual Retains Minor Holding
An investment group, including IGP Saferworld and IGP Investments (G.P.L.P), has fully divested its beneficial ownership in Cellebrite DI Ltd. by December 31, 2024, while managing director Haim Shani retains a small individual holding.
NASDAQ
SUNCORPORATION has reported a beneficial ownership of 43.7% of Cellebrite DI Ltd.'s ordinary shares, totaling 102,576,122 shares, as of December 31, 2024.